home
Registration Registration REGISTER FOR THE CONFERENCE Apply to Exhibit Apply to Exhibit APPLICATION FOR EXHIBITION Sponsorship Sponsorship SPONSORSHIP APPLICATION

Fusion

View more >
U.S. Fusion Roadmap Targets Early Power Plant Deployment by Mid-2030s

U.S. Fusion Roadmap Targets Early Power Plant Deployment by Mid-2030s

2026-08-26

The U.S. Department of Energy (DOE) recently released the "Fusion Science and Technology Roadmap," proposing to accelerate the deployment of early fusion power plants by the mid-2030s. The roadmap represents a key federal-level arrangement to advance fusion technology from experimental research toward engineering and commercialization, coordinated by the Office of Fusion established in November 2025. Unlike existing nuclear power plants that release energy through fission reactions, fusion devices attempt to fuse light atomic nuclei together, with an energy source principle identical to that of the Sun. Fusion power is regarded as a potential low-carbon energy direction, but the industry remains in the experimental and demonstration stage, with private developers yet to achieve commercial-scale net energy gain, i.e...

More >
US Pacific Fusion Breaks Ground on $1 Billion Fusion Facility in New Mexico

US Pacific Fusion Breaks Ground on $1 Billion Fusion Facility in New Mexico

2026-08-26

On August 25, local time, Pacific Fusion launched construction of a research and manufacturing campus in Albuquerque, New Mexico, USA. The project involves an investment of approximately $1 billion and will be used to build the company's fusion demonstration system, with goals including achieving net facility gain and producing high-yield fusion energy pulses. The campus is located in the Mesa del Sol area of Albuquerque. According to Pacific Fusion's plan, the demonstration system aims to achieve net energy gain at the facility level by 2030, meaning the fusion device outputs more energy than the total energy initially stored in the equipment. The company stated that if this goal is achieved, it will mark a significant technological milestone in the commercialization of fusion energy...

More >
Japan Completes Cryogenic Test of World's Largest Superconducting Toroidal Field Coil for ITER

Japan Completes Cryogenic Test of World's Largest Superconducting Toroidal Field Coil for ITER

2026-08-25

Japan's National Institutes for Quantum Science and Technology (QST) and Toshiba Corporation announced on August 25 that they had successfully completed the first cryogenic current test of the world's largest superconducting toroidal field coil at the construction site of the International Thermonuclear Experimental Reactor (ITER). The test was conducted at an operating temperature of approximately minus 269 degrees Celsius, marking a critical technical milestone before ITER's commissioning. The superconducting toroidal field coil, also known as the TF coil, installed in the test facility is a key component of ITER's superconducting magnet system, used to generate the strong magnetic field required to confine plasma. During the test, the team cooled the coil from room temperature to cryogenic conditions, confirmed its transition to the superconducting state, and for the first time achieved stable conduction of 10,000 amperes of current while the coil was in the superconducting state.

More >
US Study Shows Inertial Fusion Implosions Can Tolerate Certain Asymmetries

US Study Shows Inertial Fusion Implosions Can Tolerate Certain Asymmetries

2026-08-25

Researchers at the Lawrence Livermore National Laboratory (LLNL) in the US have recently found that implosion designs for inertial fusion energy (IFE) can withstand considerable imperfections before performance degrades sharply. This result aids in the design of fuel targets for future fusion power plants, particularly in assessing the tolerance of target capsules to errors under high-frequency injection and laser-driven conditions. The study's simulation results show the density (top) and temperature (bottom) at the instant just before fusion reactions peak in an asymmetric implosion. The hottest spot coincides with the point of highest fuel density, indicating direct ignition of high-density fuel jets driven by asymmetry. The image was recently selected for the cover of Physics of Plasmas...

More >
U.S. Department of Energy Extends Princeton University Contract to Operate PPPL

U.S. Department of Energy Extends Princeton University Contract to Operate PPPL

2026-08-25

The U.S. Department of Energy (DOE) and Princeton University have extended the contract under which Princeton University manages and operates the Princeton Plasma Physics Laboratory (PPPL). The laboratory is located on Princeton University's Forrestal Campus in Plainsboro, New Jersey. Under the new extension, the contract will be renewed for five years starting April 1, 2027. Princeton University expects to strengthen collaboration with faculty and research teams on campus during the contract period, explore next-generation fusion energy research facilities, and enhance laboratory infrastructure and safety to support ongoing operational needs. Princeton University's office for research affairs...

More >
Rock Fusion Completes Key Processes for Stellarator 3D Non-Planar Superconducting Prototype Coil

Rock Fusion Completes Key Processes for Stellarator 3D Non-Planar Superconducting Prototype Coil

2026-08-25

Recently, the stellarator high-strength stainless steel armored 3D non-planar superconducting prototype coil developed by Rock Fusion (Shanghai) Technology Co., Ltd. has completed two key processes: 3D precision winding and ground insulation wrapping. The overall 3D geometric error of the coil is consistently controlled at the millimeter level, indicating that the company has preliminarily established key manufacturing processes including material adaptation, 3D precision forming, and insulation wrapping for high-field steady-state stellarator superconducting magnets. The stellarator is an important device for steady-state controlled nuclear fusion research, and 3D superconducting coils are used to generate the complex magnetic fields required to confine plasma. Unlike conventional planar coils, stellarator coils typically feature non-planar spatial structures with continuously varying curvature...

More >

Nuclear Application

View more >

Rare Germanium Isotope Infrared Spectral Signatures Elucidated in Detail for the First Time

The press service of the Russian Ministry of Education and Science reported on August 25 that scientists from Tomsk Polytechnic University, in collaboration with an international research team, have for the first time conducted a detailed study of the infrared spectra of two rare germanium isotopes and identified characteristic spectral signatures that can be used to recognize the relevant isotopes in complex gas mixtures. The research team selected two highly enriched isotopes—germanium-72 and germanium-73—as the subjects of the study, recording their spectral information using a high-resolution Fourier transform spectrometer. This instrument is capable of resolving closely spaced spectral lines, providing the conditions for analyzing subtle spectral changes induced by isotopic substitution. The researchers stated that precise spectral data for different germanium isotopes remain relatively scarce in the scientific literature, and such data are of significant importance for identifying molecules in planetary atmospheres and for producing ultra-pure germanium isotopes for quantum technologies and modern electronics.

2026-08-26

Two production lines at radiopharmaceutical plant in Russia's Kaluga Region enter trial production

Rosatom recently announced that two production lines at its modern radiopharmaceutical manufacturing facility in the Kaluga Region have entered trial production. The facility, built in accordance with the Eurasian Economic Union's international Good Manufacturing Practice (GMP) standards, is equipped with high-level production equipment and is designed to supply safe, quality-controlled radiopharmaceuticals to the market. According to reports, Rosatom's subsidiary enterprises currently produce more than ten registered diagnostic and therapeutic radiopharmaceuticals, involving isotopes such as iodine-123, iodine-131, technetium-99m, and samarium-153. The new plant's production plan is based on the demand for radioisotope products from Russian medical institutions through 2030. The company...

2026-08-26

IAEA Study: Five-Star Rating System Can Improve CT Imaging Safety and Reduce Unnecessary Radiation Exposure

A new study led by the International Atomic Energy Agency (IAEA) in collaboration with Massachusetts General Hospital and Harvard Medical School in Boston, USA, shows that a five-star rating system can help hospitals optimize image quality, reduce radiation dose, and decrease unnecessary patient radiation exposure in computed tomography (CT) examinations. The study has been published in the European Journal of Radiology. CT imaging uses X-rays to obtain detailed images of internal body structures and is an important tool in diagnosing a wide range of diseases. The study notes that CT image quality is closely related to radiation dose—higher doses typically reduce image noise and improve clarity, but do not always yield additional diagnostic value. How to minimize radiation exposure while ensuring diagnostic accuracy is key to optimizing CT examination protocols.

2026-08-26

Singapore team develops deuterated silicon nitride waveguides for wafer-scale broadband light generation

A research team from the Singapore University of Technology and Design and the Institute of Microelectronics at the Agency for Science, Technology and Research (A*STAR) in Singapore has recently developed a low-loss deuterated silicon nitride waveguide capable of on-chip broadband light generation. By replacing hydrogen with its heavier isotope deuterium, the team fabricated silicon nitride waveguides at low temperatures, demonstrating potential for integration with CMOS-compatible semiconductor processes and wafer-scale mass production. The related paper, "Octave-spanning supercontinuum generation in wafer-scale low-loss deuterated silicon nitride waveguides," was published in *Optics Letters*. The study shows that this chip-scale waveguide can broaden infrared laser pulses to cover a spectral range from visible red light to deep infrared. Traditionally, silicon nitride thin films are grown from silane gas, and residual silicon-hydrogen bonds in the material absorb light in the telecommunications band, requiring high-temperature annealing that is incompatible with integrated electronic circuits.

2026-08-26

Thermo Fisher Scientific Launches First Orbitrap Mass Spectrometers for Isotope Ratio Analysis

Thermo Fisher Scientific recently launched the Thermo Scientific Orbitrap Isora mass spectrometer and Orbitrap Isora Pro mass spectrometer in Waltham, Massachusetts, USA. The company stated that these are its first Orbitrap instruments equipped with a dedicated isotope ratio analysis mode. The two mass spectrometers launched this time will form an integrated workflow together with the Thermo Scientific Vanquish Duo ultra-high performance liquid chromatography system and the new Isotope Discoverer software, providing molecular-level isotope ratio analysis capabilities to laboratories and researchers worldwide. Isotope ratio analysis can help researchers determine the source of compounds and their formation processes by measuring natural variations in isotopes within samples, helping...

2026-08-26

Molecular Partners Advances DLL3 Radiopharmaceutical MP0712 to Higher Dose Cohort

Swiss clinical-stage biotechnology company Molecular Partners AG recently announced its business progress and financial results for the first half of 2026. The company stated that its DLL3-targeting radioactive DARPin therapy MP0712 has advanced to the second therapeutic dose level in a U.S. multicenter Phase 1/2a clinical study, and patient enrollment for the new dose cohort is currently underway. MP0712 is a radiopharmaceutical targeting the tumor-associated antigen DLL3, carrying a therapeutic alpha-emitting radionuclide lead-212 (Pb-212) payload, co-developed by Molecular Partners and Orano Med, primarily for small cell lung cancer and other neuroendocrine tumors. According to the company's disclosure, the first dose cohort of MP0712...

2026-08-26